Skip to main content
CELL BIOTECH CO ., LTD logo

CELL BIOTECH CO ., LTD — Investor Relations & Filings

Ticker · 049960 ISIN · KR7049960008 KO Manufacturing
Open in API
Filings indexed 189 across all filing types
Latest filing 2025-02-27 AGM Information
Country KR South Korea
Listing KO 049960

About CELL BIOTECH CO ., LTD

https://www.cellbiotech.com/

CELL BIOTECH CO., LTD. is a biotechnology company specializing in the research, development, and manufacturing of probiotic solutions. With over three decades of experience, the company leverages its proprietary, worldwide-patented dual-coating technology, which is designed to ensure a higher survival rate for probiotic strains as they pass through the gastrointestinal tract. The company develops and utilizes its own GRAS (Generally Recognized as Safe) certified strains for its products. Its business encompasses the production of finished consumer products, such as the DUOLAC brand, and providing customized OEM/ODM services for the pharmaceutical and food supplement sectors.

Recent filings

Filing Released Lang Actions
주주총회집중일개최사유신고
AGM Information Classification · 95% confidence The document is a formal regulatory filing submitted to the KRX (Korea Exchange) regarding the 'Report of Reason for Holding a General Meeting on a Concentrated Date'. It explains why the company is holding its Annual General Meeting on a date that coincides with other companies' meetings, citing internal scheduling constraints. Since this is a regulatory disclosure regarding meeting logistics rather than the meeting materials themselves or a proxy statement, it falls under the general regulatory filing category.
2025-02-27 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Cell Biotech) announcing a significant change in financial results (revenue or profit structure change of 30% or more). This is a standard regulatory disclosure requirement in the Korean market (KRX) for listed companies to report preliminary financial performance changes before the final audit is completed. Since it provides key financial highlights and performance drivers rather than a full annual report or a simple announcement of a report's availability, it falls under the Earnings Release category. FY 2024
2025-02-19 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from Cell Biotech regarding a decision on cash dividends. It specifies the dividend amount per share, the total dividend amount, the record date, and the approval process. This fits the definition of a 'Notice of Dividend Amount' (DIV).
2025-02-19 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details a transaction (장내매수 - open market purchase) of shares by an executive (이상훈) of the company Cellbiotech. This is a standard regulatory filing for insider trading/director dealings in the Korean market, which corresponds to the 'Director's Dealing' category.
2025-02-12 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed in Korea. It details the change in share ownership by a company executive (Director/Managing Director) due to market sales. This type of filing is specifically categorized as 'Director's Dealing' (DIRS) as it reports personal share transactions by company insiders.
2025-02-06 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure for the purpose of holding an upcoming Annual General Meeting (AGM). It does not contain the full meeting materials or proxy statements, but rather serves as a formal notice of the procedural steps for the meeting. Given the nature of the announcement and its brevity, it falls under the category of general regulatory filings.
2024-12-16 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.